Cargando…
Using the drug-protein interactome to identify anti-ageing compounds for humans
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and...
Autores principales: | Fuentealba, Matías, Dönertaş, Handan Melike, Williams, Rhianna, Labbadia, Johnathan, Thornton, Janet M., Partridge, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342327/ https://www.ncbi.nlm.nih.gov/pubmed/30625143 http://dx.doi.org/10.1371/journal.pcbi.1006639 |
Ejemplares similares
-
Identifying Potential Ageing-Modulating Drugs In Silico
por: Dönertaş, Handan Melike, et al.
Publicado: (2019) -
Gene expression‐based drug repurposing to target aging
por: Dönertaş, Handan Melike, et al.
Publicado: (2018) -
Transcriptomic profiling of long- and short-lived mutant mice implicates mitochondrial metabolism in ageing and shows signatures of normal ageing in progeroid mice
por: Fuentealba, Matias, et al.
Publicado: (2021) -
Functional conservation in genes and pathways linking ageing and immunity
por: Fabian, Daniel K., et al.
Publicado: (2021) -
Transposable Element Landscape in Drosophila Populations Selected for Longevity
por: Fabian, Daniel K, et al.
Publicado: (2021)